Cost-effectiveness of a 4 days-a-week triple therapy in persons with HIV: an ancillary study of the QUATUOR trial

The 4/7-day strategy dominates the 7/7-day strategy, providing substantial ART-related cost savings while maintaining treatment effectiveness. Study results support generalizing the proposal of 4/7-days regimens in France, in persons eligible for this strategy.

Authors

Institutions

Publication Details

Journal
AIDS
Published
2025-04-21
DOI
https://doi.org/10.1097/qad.0000000000004215
Citations
2
Primary Topic
HIV/AIDS drug development and treatment
Type
article
Field-Weighted Citation Impact
2.79
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cost-effectiveness of a 4 days-a-week triple therapy in persons with HIV: an ancillary study of the QUATUOR trial

Christine Katlama, Clotilde Allavena, Jacqueline Capeau, Dominique G. Costagliola et al.
2 citations
AIDS
HIV/AIDS drug development and treatment
2.79
article

Cost-effectiveness of a 4 days-a-week triple therapy in persons with HIV: an ancillary study of the QUATUOR trial

Christine Katlama, Clotilde Allavena, Jacqueline Capeau, Dominique G. Costagliola, Jean‐Claude Alvarez, Sidonie Lambert-Niclot, Séverine Gibowski, Karine Lacombe, Paul Moulaire, Gilles Hejblum, Lambert Assoumou, Pierre de Truchis, Diane Ponscarme, Roland Landman, Jade Ghosn, Samih Daher, Karine Amat, Laurence Morand‐Joubert
article en
2 citations

Abstract

The 4/7-day strategy dominates the 7/7-day strategy, providing substantial ART-related cost savings while maintaining treatment effectiveness. Study results support generalizing the proposal of 4/7-days regimens in France, in persons eligible for this strategy.

AIDSVol. 39(10)
Université Claude Bernard Lyon 1 (FR), Inserm (FR), Université Paris Cité (FR), Université Paris-Saclay (FR), Centre Hospitalier Universitaire de Nantes (FR), Sorbonne Université (FR), Assistance Publique – Hôpitaux de Paris (FR), Hôpital Saint-Antoine (FR), Centre de recherche en Epidémiologie et Santé des Populations (FR), Institut de Médecine et d'Epidémiologie Africaines (FR), Institut Pierre Louis d‘Épidémiologie et de Santé Publique (FR), Centre de Recherche Saint-Antoine (FR), Hôpital Raymond-Poincaré (FR), Hôpital Saint-Louis (FR), Hôpital Bichat-Claude-Bernard (FR), Nantes Université (FR)
Openalex Percentile: Top 11%
HIV/AIDS drug development and treatment
2.79
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.